Please assess the completion status of the following clinical trial:

Trial Title: Inpatient COVID-19 Lollipop Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Ability to understand and the willingness to provide verbal informed consent, if 18 years or older. If 4-17 years old, ability to understand and the willingness to provide verbal assent, plus have a parent or legal guardian present who can provide verbal informed consent.~* Willing to comply with all study procedures and be available for the duration of the study.~* Admitted to UW Health University Hospital or UW Health Kids American Family Children's Hospital.~* Individuals at least 4 years of age.~* Verified COVID-19 according to positive NP PCR test criteria.~* Enroll within 47 hours of the diagnostic NP swab; lollipop swab collected within 48 hours of the diagnostic NP swab.~* Either personally able or have a parent or legal guardian able to verbally answer questions in English about clinical symptoms, exposures, and other health and demographic information.~Exclusion Criteria:~* Unable to suck on a swab.~* Previous participation in this study.~* Require translation services for medical care.~* Not suitable for study participation due to other reasons at the discretion of the investigators or their designee.

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- COVID-19 Positive Participants (Type: EXPERIMENTAL): Determined by NP PCR test

Based on this trial design, predict the completion outcome and termination type (if applicable).